Carfilzomib in multiple Myeloma Good Control of the cardiovascular Risk allows optimal Therapy with Proteasome Inhibitors

被引：0
|
作者：
Schmale, Ine
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 09期
关键词：
DEXAMETHASONE; LENALIDOMIDE; SURVIVAL;
D O I：
10.1159/000511030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：476 / 477
页数：2
相关论文
共 50 条
  • [1] Cardiovascular Toxicity of Proteasome Inhibitors in Multiple Myeloma Therapy
    Zheng, Yi
    Huang, Shan
    Xie, Bingxin
    Zhang, Nan
    Liu, Zhiqiang
    Tse, Gary
    Liu, Tong
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (03)
  • [2] Cardiovascular effects of multiple myeloma therapy with proteasome inhibitors
    Gavazzoni, M.
    Gorga, E.
    Vizzardi, E.
    Raddino, R.
    VASCULAR PHARMACOLOGY, 2018, 103 : 70 - 70
  • [3] Novel proteasome inhibitors as therapy in multiple myeloma
    Chauhan, D.
    Hideshima, T.
    Mitsiades, C.
    Richardson, F.
    Munshi, N.
    Anderson, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 25 - 26
  • [4] Cardiovascular Complications of Proteasome Inhibitors Used in Multiple Myeloma
    Cole, Daniel C.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2018, 26 (03) : 122 - 129
  • [5] Combination Therapy of Selinexor with Bortezomib or Carfilzomib Overcomes Drug Resistance to Proteasome Inhibitors (PI) in Human Multiple Myeloma
    Sullivan, Daniel M.
    Kashyap, Trinayan
    Dawson, Jana L.
    Landesman, Yosef
    Grant, Steven
    Shain, Kenneth H.
    Dai, Yun
    Kauffman, Michael
    Shacham, Sharon
    Turner, Joel C.
    BLOOD, 2015, 126 (23)
  • [6] Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy
    Iannaccone A.
    Bruno G.
    Ravera A.
    Gay F.
    Salvini M.
    Bringhen S.
    Sabia L.
    Avenatti E.
    Veglio F.
    Milan A.
    High Blood Pressure & Cardiovascular Prevention, 2018, 25 (2) : 209 - 218
  • [7] The proteasome and proteasome inhibitors in multiple myeloma
    Sara Gandolfi
    Jacob P. Laubach
    Teru Hideshima
    Dharminder Chauhan
    Kenneth C. Anderson
    Paul G. Richardson
    Cancer and Metastasis Reviews, 2017, 36 : 561 - 584
  • [8] The proteasome and proteasome inhibitors in multiple myeloma
    Gandolfi, Sara
    Laubach, Jacob P.
    Hideshima, Teru
    Chauhan, Dharminder
    Anderson, Kenneth C.
    Richardson, Paul G.
    CANCER AND METASTASIS REVIEWS, 2017, 36 (04) : 561 - 584
  • [9] The Cardiovascular Impact of Carfilzomib in Multiple Myeloma
    Rosenthal, Allison C.
    Luthi, Jennifer
    Belohlavek, Marek
    Mookadam, Farouk
    Mayo, Angela
    Fonseca, Rafael
    Bergsagel, P. Leif
    Reeder, Craig B.
    Mikhael, Joseph R.
    Stewart, Keith
    BLOOD, 2014, 124 (21)
  • [10] Proteasome inhibitors for multiple myeloma
    Okazuka, Kiyoshi
    Ishida, Tadao
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (09) : 785 - 792
12345